Tricor and Hyperchloraemia - a phase IV clinical study of FDA data
Hyperchloraemia is reported only by a few people who take Tricor.
The phase IV clinical study analyzes which people take Tricor and have Hyperchloraemia. It is created by eHealthMe based on reports of 21,445 people who have side effects while taking Tricor from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
21,445 people reported to have side effects when taking Tricor.
Among them, 4 people (0.02%) have Hyperchloraemia.
What is Tricor?
Tricor has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 22,123 Tricor users for its effectiveness, alternative drugs and more.
What is Hyperchloraemia?
Hyperchloraemia (an excess of chlorides in the blood) is found to be associated with 353 drugs and 151 conditions by eHealthMe.
Number of Tricor and Hyperchloraemia reports submitted per year:
Gender of people who have Hyperchloraemia when taking Tricor *:
- female: 0.0 %
- male: 100 %
Age of people who have Hyperchloraemia when taking Tricor *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 25 %
- 60+: 75 %
Common drugs people take besides Tricor *:
- Lotensin: 4 people, 100.00%
- Vioxx: 3 people, 75.00%
- Nexium: 3 people, 75.00%
- Colace: 2 people, 50.00%
- Neurontin: 1 person, 25.00%
- Golytely: 1 person, 25.00%
- Dulcolax: 1 person, 25.00%
- Amaryl: 1 person, 25.00%
- Actos: 1 person, 25.00%
Common side effects people have besides Hyperchloraemia *:
- Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 3 people, 75.00%
- Therapeutic Agent Toxicity (poisoning by ability to cure substance): 3 people, 75.00%
- Chronic Obstructive Airways Disease: 3 people, 75.00%
- Heart Attack: 3 people, 75.00%
- Chronic Obstructive Airways Disease Exacerbated: 2 people, 50.00%
- Renal Insufficiency (insufficient excretion of wastes by the kidneys): 2 people, 50.00%
- Gout (uric acid crystals building up in the body): 1 person, 25.00%
- Gastrointestinal Motility Disorder (abnormal intestinal contractions): 1 person, 25.00%
- Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 1 person, 25.00%
- Focal Segmental Glomerulosclerosis (scar tissue that forms in parts of the kidney called glomeruli): 1 person, 25.00%
Common conditions people have *:
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Tricor and have Hyperchloraemia?Check whether Hyperchloraemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Hyperchloraemia and when was it recovered:
Expand to all the drugs that have ingredients of fenofibrate:
Alternative drugs to, pros and cons of Tricor:
- Tricor (22,123 reports)
Common Tricor side effects:
Browse all side effects of Tricor:a b c d e f g h i j k l m n o p q r s t u v w x y z
Hyperchloraemia treatments and more:
- Hyperchloraemia (821 reports)
COVID vaccines that are related to Hyperchloraemia:
- Hyperchloraemia in Moderna COVID Vaccine
- Hyperchloraemia in Pfizer BioNTech Covid Vaccine
- Hyperchloraemia in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Hyperchloraemia:
- Hyperchloraemia (354 drugs)
All the conditions that are associated with Hyperchloraemia:
- Hyperchloraemia (151 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Tricor) and Tricor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ambisome and Abdominal Distension - 4 seconds ago
- Symdeko and Maternal Exposure During Pregnancy - 7 seconds ago
- Renagel and Rocaltrol drug interaction - 18 seconds ago
- Furosemide and Aggression - 20 seconds ago
- Vivitrol and Hypoglycaemia Aggravated - 22 seconds ago
- Nasonex and Reversible Ischaemic Neurological Deficit - 27 seconds ago
- Elavil and Retinal Disorder - 37 seconds ago
- Elavil and Respiratory Tract Oedema - 37 seconds ago
- Foscavir and Pulmonary Oedema - 42 seconds ago
- Hygroton and Taste - Impaired - 43 seconds ago